Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsTung‐Hung Su, Jia‐Horng Kao, Ming‐Yao Chen et al.|Liver International|2016Cited by 221
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBVChun‐Jen Liu, Pei‐Jer Chen, Wan‐Long Chuang et al.|Gastroenterology|2017Cited by 118
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 CountriesJin-Lin Hou, Seng Gee Lim, Wei Zhao et al.|Clinical Gastroenterology and Hepatology|2019Cited by 111
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsMing‐Lung Yu, Wan‐Long Chuang, Pei‐Jer Chen et al.|Journal of the Formosan Medical Association|2020Cited by 98